Skip to main content
SpringerLink
Log in

ADRs reported for multiple sclerosis drugs in Canada

  • Non-clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Tremlett HL, Oger J.Ten years of adverse drug reaction reports for the multiple sclerosis immunomodulatory therapies: a Canadian perspective. Multiple Sclerosis Journal 14: 94-105, No. 1, Jan 2008

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

ADRs reported for multiple sclerosis drugs in Canada. React. Wkly. 1202, 3 (2008). https://doi.org/10.2165/00128415-200812020-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200812020-00007

Keywords

Search

Navigation